Insider · CIK 0001337961

Healthcor L P

CIK 0001337961 Name as filed on the most recent filing

Filed as Healthcor L P (12)

38 transaction lines · from 12 filings · filed 2007-09-11 to 2011-12-07 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2011-12-06 Magellan Health Services Inc
MGLN
S, Open-market sale 500,000 disposed 48.53 24,267,000.00 Form 4, filing 0000908662-11-000213
2011-10-26 eHealth, Inc.
EHTH
P, Open-market purchase 50,000 acquired 13.91 695,410.00 Form 4, filing 0000908662-11-000194
2011-09-30 eHealth, Inc.
EHTH
P, Open-market purchase 10,000 acquired 13.92 139,191.00 Form 4, filing 0000908662-11-000194
2011-07-29 eHealth, Inc.
EHTH
P, Open-market purchase 40,000 acquired 12.93 517,088.00 Form 4, filing 0000908662-11-000194
2009-11-18 Valeant Pharmaceuticals International
VRX
S, Open-market sale 3,000,000 disposed 32.25 96,750,000.00 Form 4, filing 0000902664-09-003993
2008-10-29 Valeant Pharmaceuticals International
VRX
P, Open-market purchase 1,000,000 acquired 15.76 15,760,000.00 Form 4, filing 0000902664-08-003096
2008-03-17 Trimeris Inc
TRMS
P, Open-market purchase 463,657 acquired 6.22 2,883,946.54 Form 4, filing 0000902664-08-001614
2008-01-07 Minrad International, Inc.
BUF
P, Open-market purchase 400 acquired 3.02 1,208.00 Form 4, filing 0000902664-08-000992
2008-01-02 Minrad International, Inc.
BUF
P, Open-market purchase 61,699 acquired 3.23 199,287.77 Form 4, filing 0000902664-08-000992
2007-12-31 Minrad International, Inc.
BUF
P, Open-market purchase 53,301 acquired 3.22 171,629.22 Form 4, filing 0000902664-08-000992
2007-12-28 Minrad International, Inc.
BUF
P, Open-market purchase 10,000 acquired 3.24 32,400.00 Form 4, filing 0000902664-08-000992
2007-12-04 Minrad International, Inc.
BUF
P, Open-market purchase 16,265 acquired 2.55 41,475.75 Form 4, filing 0000902664-08-000992
2007-12-03 Minrad International, Inc.
BUF
P, Open-market purchase 25,100 acquired 2.55 64,005.00 Form 4, filing 0000902664-08-000992
2007-11-30 Minrad International, Inc.
BUF
P, Open-market purchase 97,275 acquired 2.59 251,942.25 Form 4, filing 0000902664-08-000992
2007-11-29 Minrad International, Inc.
BUF
P, Open-market purchase 78,960 acquired 2.33 183,976.80 Form 4, filing 0000902664-08-000992
2007-10-01 Trimeris Inc
TRMS
P, Open-market purchase 54,410 acquired 7.78 423,255.39 Form 4, filing 0001144204-07-052629
2007-09-28 Trimeris Inc
TRMS
P, Open-market purchase 145,590 acquired 7.64 1,112,453.19 Form 4, filing 0001144204-07-052158
2007-09-27 Trimeris Inc
TRMS
P, Open-market purchase 33,746 acquired 7.39 249,517.92 Form 4, filing 0001144204-07-052158
2007-09-21 Trimeris Inc
TRMS
P, Open-market purchase 300,000 acquired 7.11 2,133,600.00 Form 4, filing 0001144204-07-050985
2007-09-12 Minrad International, Inc.
BUF
P, Open-market purchase 12,500 acquired 4.50 56,250.00 Form 4, filing 0001144204-07-049171
2007-09-11 Minrad International, Inc.
BUF
P, Open-market purchase 5,000 acquired 4.55 22,750.00 Form 4, filing 0001144204-07-049171
2007-09-10 Minrad International, Inc.
BUF
P, Open-market purchase 33,600 acquired 4.53 152,208.00 Form 4, filing 0001144204-07-049171
2007-09-07 Minrad International, Inc.
BUF
P, Open-market purchase 5,900 acquired 4.54 26,786.00 Form 4, filing 0001144204-07-049171
2007-09-04 Minrad International, Inc.
BUF
P, Open-market purchase 46,700 acquired 4.84 226,028.00 Form 4, filing 0001144204-07-049171
2007-08-31 Minrad International, Inc.
BUF
P, Open-market purchase 40,000 acquired 4.80 192,000.00 Form 4, filing 0001144204-07-049171
2007-08-30 Minrad International, Inc.
BUF
P, Open-market purchase 13,300 acquired 4.63 61,579.00 Form 4, filing 0001144204-07-049171
2007-08-23 Minrad International, Inc.
BUF
P, Open-market purchase 40,900 acquired 4.70 192,230.00 Form 4, filing 0001144204-07-049171
2007-08-22 Trimeris Inc
TRMS
P, Open-market purchase 10,829 acquired 7.11 76,994.19 Form 4, filing 0001144204-07-048920
2007-08-21 Trimeris Inc
TRMS
P, Open-market purchase 54,525 acquired 7.07 385,655.32 Form 4, filing 0001144204-07-048920
2007-08-20 Trimeris Inc
TRMS
P, Open-market purchase 1,300 acquired 7.01 9,110.40 Form 4, filing 0001144204-07-048920
2007-08-17 Trimeris Inc
TRMS
P, Open-market purchase 9,600 acquired 7.01 67,324.80 Form 4, filing 0001144204-07-048920
2007-08-14 Minrad International, Inc.
BUF
P, Open-market purchase 55,900 acquired 4.84 270,556.00 Form 4, filing 0001144204-07-049171
2007-08-13 Minrad International, Inc.
BUF
P, Open-market purchase 3,200 acquired 4.90 15,680.00 Form 4, filing 0001144204-07-049171
2007-08-03 Minrad International, Inc.
BUF
P, Open-market purchase 585,400 acquired 4.77 2,792,358.00 Form 4, filing 0001144204-07-049171
2007-08-03 Minrad International, Inc.
BUF
P, Open-market purchase 30,600 acquired 4.64 141,984.00 Form 4, filing 0001144204-07-049171
2007-06-29 Chelsea Therapeutics International, Ltd.
CHTB.OB
S, Open-market sale 8,000 disposed 7.00 56,000.00 Form 4, filing 0001144204-07-050486
2007-06-29 Chelsea Therapeutics International, Ltd.
CHTB.OB
P, Open-market purchase 8,000 acquired 6.68 53,440.00 Form 4, filing 0001144204-07-050486
2007-03-22 Chelsea Therapeutics International, Ltd.
CHTB.OB
P, Open-market purchase 317,979 acquired 4.72 1,500,860.88 Form 4, filing 0001144204-07-050486

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. HEALTHCOR L P, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001337961

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.